Public Policy Letters, Statements, Legal Briefs, & Other Responses
-
ACMG Response to RFI on Gene Therapies Access for Rare Diseases
-
Letter to House Leadership Urging Passage of Telehealth Expansion Act of 2023
-
Letter to Senate Leadership Urging Passage of Telehealth Expansion Act of 2023
-
Sign-on Letter Supporting the Telehealth Expansion Act
-
ACMG Comment to NCD on Germline Editing and Impact on People with Disabilities
-
Sign-on Letter Urging Extension of Telehealth Flexibilities
-
Sign-on Letter Concerning Patent Legislation Negotiation Process
-
Group Sign-On Letter Regarding Telehealth Extension Legislation
-
Group Letter to Biden Administration Regarding Patent Eligibility Reform
-
Group Sign-on Letter to Congress Expressing Concerns about Patent Eligibility Reform Stakeholder Discussions